current and future treatment approaches for hr-mds
Published 2 years ago • 110 plays • Length 2:16Download video MP4
Download video MP3
Similar videos
-
1:23
the current landscape of treatment for hr-mds: an update from ash 2023
-
4:28
current and emerging treatment options for mds
-
1:06
the current state of the art in hr-mds and the need to improve treatment approaches
-
1:14
an overview of the current and future treatment landscape for mpns
-
1:04
the current standard of care for mds-related cytopenias and how treatment strategies may evolve
-
3:21
an insight into the standard of care in hr-mds and future outlooks
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml
-
2:04
state-of-the-art treatment for hr-mds
-
1:04
the future of mds management
-
1:02
emerging treatment options for lower- and higher-risk mds and ongoing trials
-
2:07
emerging targeted treatments for mds
-
2:43
novel therapies in the future of mds treatment
-
1:21
future treatment priorities for high-risk mds
-
2:33
what can artificial intelligence bring to the diagnosis and management of mds?
-
1:20
the current standard of care for patients with lower-risk mds
-
1:39
current landscape and future directions for lower-risk mds treatment
-
2:02
unmet needs in high-risk mds and future therapeutic strategies
-
1:08
approved and emerging treatment options for transplant-ineligible patients with high-risk mds
-
1:02
update on treatments for high- and low-risk mds